Research

Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.

Learn how a deadly pediatric cancer mutates a protein to cause a series of cellular malfunctions.

The flu hijacks upper lung cells and turns them into flu factories. Read how an experimental cancer drug targets the flu’s fuel and shuts the factory down.

Read how experts came together to create surveillance recommendations for children and young adults with hereditary conditions that predispose them to cancer.

The CSTN provides the world’s largest collection of pediatric cancerous tumors for research into novel treatments. Find out more about available resources.

The FDA has approved Kymriah, the first CAR T-cell therapy for acute lymphoblastic leukemia. Find out how St. Jude is planning to use this novel treatment.

Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.

St. Jude scientists, in work published in the journal Neuron, used powerful analytical tools to map what is known as the “epigenetics” of the retina.

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

NIH seminar elucidates new guidelines for grant-funded research as well as allocation of monies to more labs.